Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPILOT: Buprenorphine Initiation Strategies in Fentanyl-Using OUD Patients
NCT07469501Phase 4Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Jun 2026
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in opioid use disorder (OUD), sponsored by University of California, San Francisco. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07469501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07469501.